01228.HK
CANbridge Pharmaceuticals Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 1.92
−0.52%Margins
Gross margin
73.1%
EBITDA margin
-159.4%
EBIT margin
-185.5%
Net margin
29.6%
FCF margin
-76.5%
-4.3%
Return on equity
9.0%
Return on assets
28.5%
Return on invested capital
0.30x
Asset turnover
-HKD 44.5M
Cash from operations
HKD 0.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025